What's new

Human medicines European public assessment report (EPAR): Eylea, aflibercept, Date of authorisation: 21/11/2012, Revision: 37, Status: Authorised

Human medicines European public assessment report (EPAR): Eylea, aflibercept, Date of authorisation: 21/11/2012, Revision: 37, Status: Authorised

Jun 27, 2025 - 15:10
 0
Human medicines European public assessment report (EPAR): Eylea, aflibercept, Date of authorisation: 21/11/2012, Revision: 37, Status: Authorised
Human medicines European public assessment report (EPAR): Eylea, aflibercept, Date of authorisation: 21/11/2012, Revision: 37, Status: Authorised
Read More

Tags:

Previous Article

STAT+: The CDC’s vaccine advisory panel, empowered by RFK Jr., is just getting s...

Next Article

Human medicines European public assessment report (EPAR): Tresiba, insulin deglu...

Related Posts

Human medicines European public assessment report (EPAR): Imfinzi, durvalumab, Date of authorisation: 21/09/2018, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR...

May 16, 2025  0

Superseded Community herbal monograph on Zingiber offic...

Jun 19, 2025  0

Human medicines European public assessment report (EPAR): Blitzima, rituximab, Date of authorisation: 13/07/2017, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR...

May 23, 2025  0